EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallbericht

Lymphomatoid papulosis with DUSP22–IRF4 rearrangement: A case report and literature review

Na Niu, Meghan M Heberton, Zhenya Tang, Phyu P Aung iD, Priyadharsini Nagarajan iD, Jonathan L Curry iD, Victor G Prieto iD, Carlos A Torres-Cabala iD, Woo Cheal Cho iD

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Na Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Lymphomatoid Papulosis, Skin Neoplasms, Mycosis Fungoides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphomatoid papulosis (LyP) with DUSP22–IRF4 rearrangement is a rare, recently described variant of LyP histopathologically characterized by a biphasic growth pattern, with epidermotropic small‐to‐medium‐sized atypical T‐cells and dermal large and transformed T‐cells diffusely expressing CD30. LyP with DUSP22–IRF4 rearrangement can mimic other cutaneous lymphoproliferative disorders, particularly primary cutaneous anaplastic large cell lymphoma (PCALCL) or transformed mycosis fungoides (MF). Unlike PCALCL or transformed MF, LyP with DUSP22–IRF4 rearrangement shows an indolent clinical behavior, with frequent spontaneous regression of untreated lesions. Thus, it is important to recognize this rare variant of LyP to avoid misclassification, which may potentially lead to unnecessarily aggressive patient management. To our knowledge, only 13 cases of LyP with DUSP22–IRF4 rearrangement have been reported to date in the English literature. Herein, we describe an additional case of LyP with DUSP22–IRF4 rearrangement in a 63‐year‐old man and provide a comprehensive literature review with regards to the clinical, histopathologic, and molecular features of this novel entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphomatoid PapulosisSkin NeoplasmsMycosis FungoidesMaleHumansMiddle AgedT-LymphocytesKi-1 AntigenDual-Specificity PhosphatasesMitogen-Activated Protein Kinase Phosphatases

Stichwörter der Autor:innen

DUSP22IRF4lymphomatoid papulosismycosis fungoidesprimary cutaneous anaplastic large cell lymphoma

Substanzen

Ki-1 AntigenDUSP22 protein, humanDual-Specificity PhosphatasesMitogen-Activated Protein Kinase Phosphatases

Autor:innen und Institutionen

  • Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Phyu P Aung, Priyadharsini Nagarajan, Jonathan L Curry, Victor G Prieto, Carlos A Torres-Cabala, Woo Cheal Cho

Zitieren

APA

Niu, N., Heberton, M. M., Tang, Z., Aung, P. P., Nagarajan, P., Curry, J. L., Prieto, V. G., Torres-Cabala, C. A., & Cho, W. C. (2023). Lymphomatoid papulosis with DUSP22–IRF4 rearrangement: A case report and literature review. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14426

Vancouver

Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, et al. Lymphomatoid papulosis with DUSP22–IRF4 rearrangement: A case report and literature review. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14426

BibTeX
@article{Niu2023,
  author = {Niu, Na and Heberton, Meghan M and Tang, Zhenya and Aung, Phyu P and Nagarajan, Priyadharsini and Curry, Jonathan L and Prieto, Victor G and Torres-Cabala, Carlos A and Cho, Woo Cheal},
  title = {Lymphomatoid papulosis with DUSP22–IRF4 rearrangement: A case report and literature review},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14426}
}
Kostenlos starten →